Neogenomics (NEO) EBT Margin (2010 - 2026)
Neogenomics (NEO) reported EBT Margin of 9.42% for Q1 2026, up 585.0% on a YoY basis from 1.37% in Q1 2025, and down 44.34% quarter-over-quarter from 6.52% in Q4 2025.
Neogenomics (NEO) EBT Margin (2010 - 2026) Analysis & Trends
Neogenomics has reported EBT Margin for 17 years, with the latest figure at 9.42% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 585.0% year-over-year to 9.42%; the trailing twelve-month figure through Mar 2026 stood at 13.7% (down 200.0% YoY), and the FY2025 full-year result was 15.16%, down 295.0% from the prior year.
- EBT Margin for Q1 2026 stood at 9.42%, down from 6.52% in the prior quarter.
- The five-year high for EBT Margin was 6.52% in Q4 2025, with the low at 45.37% in Q1 2022.
- Historically, EBT Margin has averaged 18.46% across 5 years, with a median of 15.27% in 2025.
- Annual changes were most pronounced in 2022 — EBT Margin slumped 9314 bps — and 2023, when it surged 2080 bps.
- Neogenomics' EBT Margin stood at 18.4% in 2022, then jumped by 47 bps to 9.83% in 2023, then increased by 5 bps to 9.38% in 2024, then soared by 30 bps to 6.52% in 2025, then plunged by 44 bps to 9.42% in 2026.
- The last three EBT Margin figures came in at 9.42% (Q1 2026), 6.52% (Q4 2025), and 14.05% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -6.95% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 15.76% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 20.75% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.16% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 22.23% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 7.90% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -12.17% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 14.39% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 22.14% |
| 10 | Neogenomics | 1.41 Bn | 1.27 Bn | 80.86 Mn | -9.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.42% |
| Dec 31, 2025 | -6.52% |
| Sep 30, 2025 | -14.05% |
| Jun 30, 2025 | -25.27% |
| Mar 31, 2025 | -15.27% |
| Dec 31, 2024 | -9.38% |
| Sep 30, 2024 | -10.64% |
| Jun 30, 2024 | -11.56% |
| Mar 31, 2024 | -17.72% |
| Dec 31, 2023 | -9.83% |
| Sep 30, 2023 | -14.12% |
| Jun 30, 2023 | -18.13% |
| Mar 31, 2023 | -24.57% |
| Dec 31, 2022 | -18.40% |
| Sep 30, 2022 | -30.77% |
| Jun 30, 2022 | -32.81% |
| Mar 31, 2022 | -45.37% |
| Dec 31, 2021 | -35.16% |
| Sep 30, 2021 | -19.10% |
| Jun 30, 2021 | 60.33% |